GLOBAL TB REALITIES
- TB is an airborne disease
- 4,000 people a day die from TB, 1.5 million a year
- 500,000 people today live with multi-drug resistant TB
- TB is a leading killer among people living with HIV
- TB is closely linked with social and economic marginalization
- TB is mostly found in the "BRICS" countries, and in low-income settings
Q: Who is AA&D?
A. Advance Access & Delivery is a new initiative driving and supporting Zero TB Cities Project alongside key partners around the world. Read more here.
Q. Why cities?
A. Cities have their own resource base to fight the disease, strong institutions, and concentrated pockets of TB patients. Our work is centered on cities but is not exclusive to them, working toward elimination in any defined geographical area.
Q: Who funds AA&D?
A: We are funded by individuals, academic partnerships, foundations, multilaterals, and corporate support. Today, our initiative is housed within Partners In Health, 501(c)3, a leader in global health delivery, as fiscal agent.
Q: Where are your sites?
A: Our first two Zero TB Cities Project sites are in Chennai, India, and Lima, Peru. Both are among the largest cities on their respective continents and are tackling significant TB threats. New cities are working with us to consider launching in their
Global policy advocacy highlight - Building consensus for equitable care
From April 12 through April 16, over 70 practitioners and policy experts in the area of TB care met for intensive practical sessions on treatment of latent TB infection, second-line drug supply chain innovations, and the Zero TB Cities project.
AN INITIAL FOCUS ON TUBERCULOSIS IN CITIES
WORKING TO CREATE "ISLANDS OF ELIMINATION" WITH STRONG LOCAL PARTNERS IN HIGH-BURDEN AREAS, UTILIZING A PROVEN, COMPREHENSIVE, COMMUNITY-BASED CARE PLATFORM.
By focusing on municipal areas in high-burden countries, including the so-called BRICS group of countries (Brazil-Russia-India-China-South Africa), where 60% of the world's TB is found, AA&D is facilitating the creation of sustainable new coalitions of care providers among local associations, NGOs, research institutions and governments who are ready to deliver world-class care to the populations they represent on a long terms basis. Initially, the focus is on cities, where most of the world's population now lives.
THE TIME IS NOW: A GLOBAL HEALTH PARADIGM SHIFT IS IMMINENT
Disease control frameworks in the Global North provide AA&D an evidence-based foundation for standards of care against infectious diseases, divorced from questions of resource availability. The job is to find the "how" for tackling these diseases with local tools in local contexts, not how to lower the standards. This can include taking advantage of the flexibility of the private sector in some settings, but only when it does not entail the false condition of reducing public investment in proven disease control programs.
PROGRAMS THAT APPLY THE HIGHEST STANDARDS SEE EXCELLENT RESULTS, ACROSS THE ECONOMIC DIVIDE
There is rigorous evidence base showing that complex disease interventions and health promotion activities work in both wealthy health systems and more challenging environments, given appropriate programmatic supports. Partners In Health (PIH) is a leader in global health delivery and research in these challenging settings, and an institutional and fiscal partnership between the Zero TB Cities Project and PIH strengthens the clinical and programmatic components of our work. Research teams also hold appointments at Harvard Medical School's (HMS) Department of Global Health and Social Medicine and Duke University's Sanford School of Public Policy. See more about the partnership with HMS and Janssen Global that allowed for the development of this platform, and our colleagues at Duke University working to broaden this partnership (external link).